ES2348203T3 - Eritrovirus y sus aplicaciones. - Google Patents

Eritrovirus y sus aplicaciones. Download PDF

Info

Publication number
ES2348203T3
ES2348203T3 ES98958322T ES98958322T ES2348203T3 ES 2348203 T3 ES2348203 T3 ES 2348203T3 ES 98958322 T ES98958322 T ES 98958322T ES 98958322 T ES98958322 T ES 98958322T ES 2348203 T3 ES2348203 T3 ES 2348203T3
Authority
ES
Spain
Prior art keywords
erythrovirus
seq
sequences
genome
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98958322T
Other languages
English (en)
Spanish (es)
Inventor
Antoine Garbarg-Chenon
Quang Tri Nguyen
Veronique Auguste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Application granted granted Critical
Publication of ES2348203T3 publication Critical patent/ES2348203T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14211—Erythrovirus, e.g. B19 virus
    • C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES98958322T 1997-12-03 1998-12-03 Eritrovirus y sus aplicaciones. Expired - Lifetime ES2348203T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715197 1997-12-03
FR9715197A FR2771751B1 (fr) 1997-12-03 1997-12-03 Erythrovirus et ses applications

Publications (1)

Publication Number Publication Date
ES2348203T3 true ES2348203T3 (es) 2010-12-01

Family

ID=9514085

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98958322T Expired - Lifetime ES2348203T3 (es) 1997-12-03 1998-12-03 Eritrovirus y sus aplicaciones.

Country Status (12)

Country Link
US (2) US7291452B1 (de)
EP (1) EP1037916B1 (de)
JP (1) JP4831864B2 (de)
AT (1) ATE469169T1 (de)
AU (1) AU757453B2 (de)
CA (1) CA2311297C (de)
DE (1) DE69841687D1 (de)
DK (1) DK1037916T3 (de)
ES (1) ES2348203T3 (de)
FR (1) FR2771751B1 (de)
PT (1) PT1037916E (de)
WO (1) WO1999028439A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2771751B1 (fr) * 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris Erythrovirus et ses applications
US6642033B1 (en) * 1999-07-20 2003-11-04 V.I. Technologies, Inc. Nucleic acids for detecting parvovirus and methods of using same
AU2002323520B2 (en) 2001-08-31 2008-02-21 Gen-Probe Incorporated Assay for detection of human parvovirus B19 nucleic acid
ES2422583T3 (es) * 2004-02-10 2013-09-12 Hoffmann La Roche Detección de parvovirus B19
US20060057643A1 (en) * 2004-09-10 2006-03-16 Mccarthy Laurence R Methods and compositions for detecting erythrovirus genotypes
AU2005333163B2 (en) 2004-11-09 2011-06-16 Gen-Probe Incorporated Compositions and methods for detecting Group A streptococci
WO2007096199A2 (en) * 2006-02-22 2007-08-30 Ikdt Institut Kardiale Diagnostik Und Therapie Gmbh Differential diagnostics and therapy of virally induced heart muscle disease
AU2008206309A1 (en) * 2007-01-16 2008-07-24 Talecris Biotherapeutics, Inc. Human erythrovirus
WO2009038840A2 (en) * 2007-06-14 2009-03-26 Ibis Biosciences, Inc. Compositions for use in identification of adventitious contaminant viruses
CA2756659A1 (en) 2009-02-26 2010-09-02 Gen-Probe Incorporated Assay for detection of human parvovirus nucleic acid
US9598739B1 (en) 2009-03-13 2017-03-21 Grifols Therapeutics Inc. Human erythrovirus
CN103154242B (zh) 2010-07-06 2015-09-30 诺华股份有限公司 诺如病毒衍生的免疫原性组合物和方法
WO2013012708A1 (en) 2011-07-15 2013-01-24 Gen-Probe Incorporated Compositions and method for detecting human parvovirus nucleic acid and for detecting hepatitis a virus nucleic acids in single-plex or multiplex assays

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322417A1 (de) * 1986-09-08 1989-07-05 Applied Biotechnology, Inc. Leere virus kapsidvakzine
WO1990005538A1 (en) * 1988-11-14 1990-05-31 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Parvovirus capsids
NL8902301A (nl) 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.
US6204044B1 (en) * 1989-09-14 2001-03-20 Caroline Sarah Brown Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
US6287815B1 (en) * 1989-09-14 2001-09-11 Rijksuniversiteit Te Leiden Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
US6274307B1 (en) * 1990-02-08 2001-08-14 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologically active peptides or polypeptides from the parvovirus B19
DE4003826C2 (de) * 1990-02-08 1995-11-23 Mikrogen Molekularbiol Entw Peptide der Kapsidproteine VP1 oder VP2 des Parvovirus B19
JPH07147986A (ja) * 1992-09-24 1995-06-13 Denki Kagaku Kogyo Kk ヒトパルボウイルス遺伝子、それによってコ−ドされるポリペプチド及び用途
WO1996009391A2 (en) * 1994-09-22 1996-03-28 Hans Wolf Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
FR2771751B1 (fr) 1997-12-03 2000-05-26 Assist Publ Hopitaux De Paris Erythrovirus et ses applications
DE10030677A1 (de) 2000-02-15 2001-08-16 Peter Hechler Schuhwerk mit einer Decksohle
US6668044B1 (en) 2000-07-19 2003-12-23 Xtend Communications Corp. System and method for recording telephonic communications

Also Published As

Publication number Publication date
DE69841687D1 (de) 2010-07-08
JP2001525163A (ja) 2001-12-11
US7291452B1 (en) 2007-11-06
US20080248528A1 (en) 2008-10-09
AU757453B2 (en) 2003-02-20
AU1440399A (en) 1999-06-16
FR2771751B1 (fr) 2000-05-26
ATE469169T1 (de) 2010-06-15
EP1037916B1 (de) 2010-05-26
PT1037916E (pt) 2010-08-30
FR2771751A1 (fr) 1999-06-04
WO1999028439A2 (fr) 1999-06-10
DK1037916T3 (da) 2010-09-27
WO1999028439A3 (fr) 1999-07-22
CA2311297C (fr) 2012-10-02
CA2311297A1 (fr) 1999-06-10
JP4831864B2 (ja) 2011-12-07
EP1037916A2 (de) 2000-09-27
US8105610B2 (en) 2012-01-31

Similar Documents

Publication Publication Date Title
US8105610B2 (en) Method of making novel erythrovirus V9 VP2 capsid polypeptides
US7947452B2 (en) Oligonucleotides originating from sequences coding for the surface component of PTLV envelope proteins and their uses
JP5829830B2 (ja) Ｅ型肝炎ウイルスのポリペプチド断片、それを含むワクチン組成物及び診断キット、並びにその使用
IE65172B1 (en) Viral agent
JPH05506773A (ja) 新規のｈｃｖ分離株
CA2197569A1 (en) Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus
KR0178399B1 (ko) 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프
Moussa et al. Haemorrhagic disease of lagomorphs: evidence for a calicivirus
DK3063298T3 (en) HCBI SEQUENCES AS AN EARLY MARKER FOR FUTURE DEVELOPMENT OF CANCER AND DISEASES IN CNS AND AS A TARGET FOR TREATMENT AND PREVENTION OF CANCER
US5800981A (en) Human cytomegalovirus antigen and its use
EP2044950B1 (de) Abgeschwächte Vif-DNA-Immunisierungskassetten für genetische Impfstoffe
He et al. Mutations in the ‘a’determinant of hepatitis B surface antigen among Chinese infants receiving active postexposure hepatitis B immunization
JP3809502B2 (ja) ハンタウィルス抗原蛋白質およびモノクローナル抗体
ES2276468T3 (es) Secuencias retroviricas endogeneticas, asociados con efermedades autoinmunitarias y/o con transtornos del embarazo.
US6110465A (en) Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines
MXPA02005655A (es) Virus centinela (sv1) del virus de la hepatitis.
Cardoso et al. The serology of hepatitis C virus (HCV) infection: antibody crossreaction in the hypervariable region 1
WO2022199526A1 (en) Hepatitis e virus-like particles and uses thereof
JPH06321991A (ja) Ｂ型肝炎ウイルス由来のポリペプチドおよびそれをコードする遺伝子
JP3484727B2 (ja) Ｂ型肝炎ウイルス由来のポリペプチドおよびそれをコードする遺伝子
ZA200607741B (en) Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays
JPH061799A (ja) 非ａ非ｂ型肝炎ウイルス抗原ペプチド、該ペプチドをコードする核酸断片およびその利用法
ITMI982437A1 (it) Molecole di acido nucleico che rappresentano un virus trasmissibileper via parenterale.
KR19980032276A (ko) 서울 바이러스 r22의 뉴클레오캡시드 단백질 유전자, 재조합 플라스미드, 형질전환 대장균, 및 신증후 출혈열 진단제 및 예방백신
NZ528739A (en) A mutant human hepatitis B viral strain and uses thereof